Cargando…
Triptolide and its prodrug minnelide suppress Hsp70 and inhibit in vivo growth in a xenograft model of mesothelioma
Malignant mesothelioma is a devastating disease with a poor prognosis for which there is a clear need for more successful therapeutic approaches. Triptolide, a diterpenoid triepoxide, is a highly effective agent against several cancer types in animal models. Owing to triptolide's poor solubilit...
Autores principales: | Jacobson, Blake A., Chen, Esther Z., Tang, Shaogeng, Belgum, Holly Sedgwick, McCauley, Joel A., Evenson, Kristen A., Etchison, Ryan G., Jay-Dixon, Joe, Patel, Manish R., Raza, Ahmad, Saluja, Ashok K., D'Cunha, Jonathan, Kratzke, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426951/ https://www.ncbi.nlm.nih.gov/pubmed/26000097 |
Ejemplares similares
-
Minnelide: A Novel Therapeutic That Promotes Apoptosis in Non-Small Cell Lung Carcinoma In Vivo
por: Rousalova, Ilona, et al.
Publicado: (2013) -
Minnelide/Triptolide Impairs Mitochondrial Function by Regulating SIRT3 in P53-Dependent Manner in Non-Small Cell Lung Cancer
por: Kumar, Ajay, et al.
Publicado: (2016) -
Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer
por: Arora, Nivedita, et al.
Publicado: (2017) -
Minnelide effectively eliminates CD133(+) side population in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2015) -
Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia
por: Giri, Bhuwan, et al.
Publicado: (2019)